| National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed)- RFA-AI-22-058 |
U01
|
August 09, 2022 |
December 01, 2022 |
| Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed)- RFA-AI-22-057 |
U01
|
August 09, 2022 |
December 01, 2022 |
| Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01 Clinical Trial Not Allowed)- RFA-AI-22-054 |
U01
|
August 09, 2022 |
December 01, 2022 |
| Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)- PAR-22-223 |
R01
|
August 09, 2022 |
December 08, 2024 |
| Notice of Special Interest (NOSI)—Opportunities for HIV Cure Interventions at the Time of ART Initiation- NOT-AI-22-056 |
R01, R21
|
August 05, 2022 |
September 08, 2025 |
| Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)- PAR-22-222 |
R01
|
August 04, 2022 |
December 08, 2024 |
| Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed)- RFA-AI-22-046 |
R01
|
July 20, 2022 |
November 10, 2022 |
| Point-of-Care Technologies Research Network—Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional)- PAR-22-203 |
U54
|
July 13, 2022 |
January 08, 2023 |
| Notice of Special Interest (NOSI)—Research on the Health of Sexual and Gender Minority (SGM) Populations- NOT-MD-22-012 |
Multiple |
July 11, 2022 |
August 08, 2025 |
| Regenerative Medicine Innovation Projects (RMIP) Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) - RFA-HL-23-020 |
R34
|
July 08, 2022 |
October 07, 2022 |
| Regenerative Medicine Innovation Projects (RMIP) Investigator- Initiated Studies (Collaborative U01 Clinical Trial Not Allowed)- RFA-HL-23-019 |
U01
|
July 08, 2022 |
October 07, 2022 |
| Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)- RFA-HL-23-017 |
UG3/UH3
|
July 08, 2022 |
October 07, 2022 |
| Notice of Special Interest—Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease- NOT-AG-22-025 |
Supp
|
July 07, 2022 |
October 02, 2022 |
| CCRP Initiative—Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)- PAR-22-209 |
UG3/UH3
|
July 06, 2022 |
October 18, 2024 |
| Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)- RFA-AI-22-050 |
R01
|
June 27, 2022 |
December 08, 2022 |
| Limited Competition—A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)- RFA-CA-22-026 |
U24
|
June 14, 2022 |
September 16, 2022 |
| Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 Clinical Trial Not Allowed)- RFA-ES-22-003 |
U24
|
June 06, 2022 |
August 26, 2022 |
| Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed) - RFA-NS-22-051 |
U2C
|
June 06, 2022 |
August 11, 2022 |
| Notice of Special Interest (NOSI)— Innovative Technologies for Research on Climate Change and Human Health Small Business Technology Transfer (R41/R42 Clinical Trial Optional)- NOT-ES-22-009 |
R41/R42
|
June 03, 2022 |
April 06, 2023 |
| Notice of Special Interest (NOSI)—Innovative Technologies for Research on Climate Change and Human Health Small Business Innovation Research (R43/R44 Clinical Trial Optional)- NOT-ES-22-010 |
R43/R44
|
June 03, 2022 |
April 06, 2023 |
| PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)- PA-22-176 |
R43/R44
|
June 02, 2022 |
April 06, 2023 |
| PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)- PA-22-178 |
R41/R42
|
June 02, 2022 |
April 06, 2023 |
| Notice of Special Interest (NOSI)— Climate Change and Health- NOT-ES-22-006 |
Multiple |
June 01, 2022 |
May 08, 2025 |
| Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)- PAR-22-185 |
X01
|
May 27, 2022 |
January 18, 2025 |
| A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed)- RFA-AI-22-038 |
P01
|
May 27, 2022 |
October 14, 2022 |
